Evidence at a glance
Status and evidence table
| Peptide | Canada status | Human evidence |
|---|---|---|
| Epitalon (Epithalon) | Not authorized in Canada | Very limited: almost all animal or cell studies |
| MOTS-c | Not authorized in Canada | Very limited: almost all animal or cell studies |
| Humanin | Not authorized in Canada | Very limited: almost all animal or cell studies |
| SS-31 (Elamipretide) | Not authorized in Canada (approved elsewhere) | Limited: small or low-quality human studies (rare disease; accelerated approval) |
Status reflects Health Canada's peptide pages, its April 2026 advisory and the Drug Product Database as checked on November 10, 2026. Authorized products carry an 8-digit DIN (drugs) or NPN (natural health products).
